Michael T Bowen
Biographic Data
| ID | 6261112 |
|---|---|
| NAME | Michael T Bowen |
| GIVEN NAMES | Michael T |
| FAMILY NAME | Bowen |
| SIGNATURE | BOWEN M T |
| AFFILIATIONS | The University of Sydney |
| ORCID | 0000-0002-8965-4136 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2022 |
| H-INDEX | 0 |
Off-target pharmacological profiling of synthetic cannabinoid receptor agonists including AMB-Fubinaca, Cumyl-Pinaca, PB-22, and XLR-11
These results suggest that while some "off-targets" could possibly contribute to the SCRA toxidrome, particularly at high concentrations, CB1-mediated cellular dysfunction provides support for hypotheses concerning on-target, rather than off-target, toxicity. Further investigation of non-GPCR off-targets is warranted
Sucrose intake by rats affected by both intraperitoneal oxytocin administration and time of day
No prominent works on this page.
Off-target pharmacological profiling of synthetic cannabinoid receptor agonists including AMB-Fubinaca, Cumyl-Pinaca, PB-22, and XLR-11
These results suggest that while some "off-targets" could possibly contribute to the SCRA toxidrome, particularly at high concentrations, CB1-mediated cellular dysfunction provides support for hypotheses concerning on-target, rather than off-target, toxicity. Further investigation of non-GPCR off-targets is warranted
Sucrose intake by rats affected by both intraperitoneal oxytocin administration and time of day
Chemistry (2 works) · Agonist (1 work) · Anesthesia (1 work) · Biochemistry (1 work) · Biology (1 work) · Birth, Development, and Health (1 work) · Cannabinoid (1 work) · Cannabinoid receptor (1 work) · Cannabinoid Receptor Agonists (1 work) · Cannabinoid receptor type 2 (1 work)